This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oriental Yeast Co., Ltd.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Yasutaka Kaneda: Innovator in Cerebral Apoplexy Diagnosis
Introduction
Yasutaka Kaneda is a prominent inventor based in Osaka-fu, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of cerebral apoplexy. His innovative work has led to the development of a novel marker that aids in the diagnosis of this critical condition.
Latest Patents
Yasutaka Kaneda holds 1 patent for his invention titled "Marker for cerebral apoplexy." This patent describes a method where a sample is treated with a phosphoglyceric acid mutase (PGAM) inhibitor, specifically polythionic acid (salt) such as potassium tetrathionate. This process inactivates the M-type isozyme activity, allowing for the quantification of the B-type PGAM through a rate assay. The B-type PGAM serves as a novel marker for cerebral apoplexy, enabling accurate diagnosis through its assay.
Career Highlights
Kaneda is associated with Oriental Yeast Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical diagnostics and patient care.
Collaborations
He has collaborated with notable colleagues, including Hitoshi Takeshita and Hiroshi Morita, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yasutaka Kaneda's contributions to the field of cerebral apoplexy diagnosis exemplify the importance of innovation in medical science. His work not only enhances diagnostic capabilities but also paves the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile